In patients with BRCA1/2 mutations, common chemotherapy not found to be heart toxic
Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations -- despite preclinical evidence that such...